/Investor DB

SpringTide Ventures — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

Biotiabiotia.ioin𝕏Aug 2022 · $8M

Biotia develops infectious disease diagnostics using clinical metagenomic next-generation sequencing paired with artificial intelligence, offering diagnostic tests and genomics software for patients, providers, and health systems managing challenging infections.

AI & Machine LearningBiotechDigital Health

Chris Mason(Founder)inNiamh O'Hara(Founder & CEO)inNiamh B. O'Hara(Founder)in

Co-investorsCloquet Capital Partners, LLCConvergent VenturesDigitalDx VenturesEverywhere VenturesHyperplane Venture CapitalMEDA Angels+11 more

RXLiverxlive.comApr 2022

RxLive provides telehealth pharmacist services, software, and analytics to integrate clinical pharmacists into the healthcare team under a "value-based pharmacy" model.

Digital HealthHealthtechSaaSSt. Petersburg, US

MARK ENGELEN(Executive Officer, Director)

BoardKRISTIN GRECO(Director)LORAINE DAUGHERTY(Director)SEAN McNAMARA(Director)

Co-investorsAxial Capital PartnersDreamit Ventures

Source Defensesourcedefense.comin𝕏Apr 2022 · $27M

Source Defense provides a client-side security platform that detects and prevents digital skimming, Magecart attacks, and threats from third-party JavaScript on websites and payment pages.

CybersecurityEnterprise SoftwareSaaS

Co-investorsAllegisCyber CapitalBenhamou Global VenturesBGVConnecticut InnovationsGlobal BrainSixThirty Ventures+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.